How many institutions held AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value in Q3 2023?

45 institutional investors reported AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value for Q3 2023. Use the holders table for investor-level position and value details.

Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST)

Q: What does CUSIP 03843E104 represent in this 13F holders report?

CUSIP 03843E104 is the security identifier for AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value used to aggregate holder disclosures.

CUSIP: 03843E104

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class: Equity / Common Stock, $0.001 par value
Shares outstanding: 120,192,308
Total 13F shares: 13,082,950
Share change: +3,817,420
Total reported value: $20,018,501
Put/Call ratio: 17%
Price per share: $1.53
Number of holders: 45
Value change: +$5,799,587
Number of buys: 17
Number of sells: 26

Quarterly Holders Quick Answers

What is CUSIP 03843E104?
CUSIP 03843E104 identifies AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Institutional Holders of Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) as of Q3 2023

As of 30 Sep 2023, Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) was held by 45 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,082,950 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Vahanian & Associates Financial Planning Inc., ACADIAN ASSET MANAGEMENT LLC, BlackRock Inc., Corient Private Wealth LLC, GEODE CAPITAL MANAGEMENT, LLC, Bracebridge Capital, LLC, and MARSHALL WACE, LLP. This page lists 45 institutional shareholders reporting positions in this security for the Q3 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.